Pharmaceutical and biotechnology professionals are given the rare opportunity to view the oncology space, its future and its current operational issues from the provider and payer perspective. Participants will improve their working knowledge of key business, policy, coverage, reimbursement, informational, and operational issues in oncology and will gather valuable insights material to developing effective strategies for navigating the various constituencies in cancer care. Through this interactive program, pharmaceutical and biotech professionals will learn from key stakeholders what they view to be the most pressing issues in oncology today and how to apply this knowledge to create mutually-successful working relationships.
Professionals from marketing, sales, medical affairs, clinical research, policy and government affairs, and other business areas all will be better able to serve their customers with improved knowledge of real-world oncology issues after completion of this program.
Curriculum – Day 1, July 10, 2013
9:00 AM ̶ 3:00 PM
Moderator:
Clifford Goodman, PhD
The Lewin Group
Module I:
The Affordable Care Act – Communicating the New Normal to Patients: Who Will be Responsible?
Carolyn Aldige
Prevent Cancer Foundation
Karen Ignani, MBA (Invited)
America's Health Insurance Plans
Rachel Klein
Enroll America
Ira Klein, MD
Aetna
Terry Langbaum, MAS
The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Cheryl Larson
Midwest Business Group on Health
Leonard Saltz, MD
Memorial Sloan-Kettering Cancer Center
Module II:
Effective Pricing in a New Era: What is the Value Equation?
(co-presented by Xcenda, LLC)
Sylvia Bartel, MPH (Invited)
Dana-Farber/Brigham and Women's Cancer Center
Massachusetts General Hospital Cancer Center
Barry Fortner, PhD
ION Solutions
Ira Klein, MD
Aetna
Leonard Saltz, MD
Memorial Sloan-Kettering Cancer Center
Asif Velani, MBA
Genentech
Module III:
Meet the Regulatory and Reimbursement Experts
(co-presented by Xcenda, LLC)
Tom Grissom
Foley Hoag
Ira Klein, MD
Aetna
Barry Straube, MD
The Marwood Group
Curriculum – Day 2, July 11, 2013
8:15 AM – 12:00 PM
Moderator:
Robert W. Carlson, MD, CEO
National Comprehensive Cancer Network
Module IV:
Meet the Experts: NCCN Guidelines® Hot Topics
Al B. Benson III, MD
Robert H. Lurie Comprehensive Cancer
Center of Northwestern University
Ellin Berman, MD (Invited)
Memorial Sloan-Kettering Cancer Center
David S. Ettinger, MD
The Sidney Kimmel Comprehensive
Cancer Center at Johns Hopkins
Module V:
Defining Quality in Oncology
Stephen B. Edge, MD
Roswell Park Cancer Institute
John Fox, MD
Priority Health
Bruce Gould, MD
Northwest Georgia Oncology Centers
Clifford A. Hudis, MD
Memorial Sloan-Kettering Cancer Center/American Society of Clinical Oncology
Marcus Neubauer, MD
McKesson Specialty Health
Art Small, MD
Genentech
*Subject to change
Enroll today and save $100. Discounted registration expires Friday, June 28, 2013
Before 6.28.2013 |
After 6.28.2013 |
|
Industry Registrants |
$2,395 |
$2,495 |
Corporate Council Member |
$2,295 |
$2,395 |
Academy Alumni |
$2,195 |
|
Ten people or more from the same company |
$2,150 |
Please check back often for the latest information. Please contact 866.788.NCCN (6226) or contact Jon Larsen, Manager, Global Business Development.
Permission licenses are available to purchase exclusive video footage of recent NCCN Academy for Excellence & Leadership in Oncology™ School of Pharmaceutical & Biotech Business programs for viewing by internal company representatives for one year.
NCCN offers the unique opportunity to customize an NCCN Academy curriculum that best aligns with your organization's particular needs and interests.
Approximately 97 percent of recent NCCN Academy attendees say they would attend an NCCN Academy program again or recommend that colleagues attend.
| Quick Links |
|
|
About NCCN| NCCN Member Institutions| Patient Resources| NCCN Foundation| Privacy Policy| Legal Notices| Contact Us
275 Commerce Drive, Suite 300, Fort Washington, PA 19034 • 215.690.0300 • Fax: 215.690.0280
Copyright © 2013 National Comprehensive Cancer Network, All Rights Reserved